<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Little is known about <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors' receptivity to being contacted through <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries for research and health promotion efforts </plain></SENT>
<SENT sid="1" pm="."><plain>We sought to (1) determine breast and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) survivors' responsiveness to a mailed survey using an academic medical center's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry, (2) assess whether responsiveness varied according to sociodemographic characteristics and medical history, and (3) examine the prevalence and correlates of respondents' awareness and willingness to be contacted through the state <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry for future research studies </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Stage 0-III breast and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> survivors diagnosed between January 2004 and December 2009 were identified from an academic medical center <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry </plain></SENT>
<SENT sid="3" pm="."><plain>Survivors were mailed an invitation letter with an opt-out option, along with a survey assessing sociodemographic characteristics, medical history, and follow-up <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> care access and utilization </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 452 (31.4 %) breast and 53 (22.2 %) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> survivors responded </plain></SENT>
<SENT sid="5" pm="."><plain>Willingness to be contacted through the state <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry was high among both breast (74 %) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (64 %) respondents even though few were aware of the registry and even fewer knew that their information was in the registry </plain></SENT>
<SENT sid="6" pm="."><plain>In multivariable analyses, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage I and not having a family history of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were associated with willingness among breast and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> survivors, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our findings support the use of state <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries to contact survivors for participation in research studies </plain></SENT>
<SENT sid="8" pm="."><plain>IMPLICATIONS FOR <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">CANCER</z:e> SURVIVORS: Survivors would benefit from partnerships between researchers and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries that are focused on health promotion interventions </plain></SENT>
</text></document>